These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

212 related articles for article (PubMed ID: 37743336)

  • 21. From process to progress-2017 International Conference on Neurofibromatosis 1, Neurofibromatosis 2 and Schwannomatosis.
    Ferner RE; Bakker A; Elgersma Y; Evans DGR; Giovannini M; Legius E; Lloyd A; Messiaen LM; Plotkin S; Reilly KM; Schindeler A; Smith MJ; Ullrich NJ; Widemann B; Sherman LS
    Am J Med Genet A; 2019 Jun; 179(6):1098-1106. PubMed ID: 30908866
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Plasminogen activation in neurofibromatosis 2-associated and sporadic schwannomas.
    Sirén V; Antinheimo JP; Jääskeläinen J; Böhling T; Carpén O; Vaheri A
    Acta Neurochir (Wien); 2004 Feb; 146(2):111-8. PubMed ID: 14963743
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Segmental neurofibromatosis type 2: discriminating two hit from four hit in a patient presenting multiple schwannomas confined to one limb.
    Castellanos E; Bielsa I; Carrato C; Rosas I; Solanes A; Hostalot C; Amilibia E; Prades J; Roca-Ribas F; Lázaro C; Blanco I; Serra E;
    BMC Med Genomics; 2015 Jan; 8():2. PubMed ID: 25739810
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Neurofibromatosis- and schwannomatosis-associated tumors: Approaches to genetic testing and counseling considerations.
    Goetsch Weisman A; Weiss McQuaid S; Radtke HB; Stoll J; Brown B; Gomes A
    Am J Med Genet A; 2023 Oct; 191(10):2467-2481. PubMed ID: 37485904
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Management of neurofibromatosis type 2 and schwannomatosis associated peripheral and intraspinal schwannomas: influence of surgery, genetics, and localization.
    Gugel I; Grimm F; Tatagiba M; Schuhmann MU; Zipfel J
    J Neurooncol; 2022 Sep; 159(2):271-279. PubMed ID: 35771312
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Neurofibromatosis type 2 (NF 2) or schwannomatosis?--Case report study and diagnostic criteria.
    Radek M; Tomasik B; Wojdyn M; Snopkowska-Wiaderna D; Błaszczyk M; Radek A
    Neurol Neurochir Pol; 2016; 50(3):219-25. PubMed ID: 27154453
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The neurofibromatoses. Part 2: NF2 and schwannomatosis.
    Lu-Emerson C; Plotkin SR
    Rev Neurol Dis; 2009; 6(3):E81-6. PubMed ID: 19898272
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A case of multiple cutaneous schwannomas; schwannomatosis or neurofibromatosis type 2?
    Murray AJ; Hughes TA; Neal JW; Howard E; Evans DG; Harper PS
    J Neurol Neurosurg Psychiatry; 2006 Feb; 77(2):269-71. PubMed ID: 16421138
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Updated diagnostic criteria and nomenclature for neurofibromatosis type 2 and schwannomatosis: An international consensus recommendation.
    Plotkin SR; Messiaen L; Legius E; Pancza P; Avery RA; Blakeley JO; Babovic-Vuksanovic D; Ferner R; Fisher MJ; Friedman JM; Giovannini M; Gutmann DH; Hanemann CO; Kalamarides M; Kehrer-Sawatzki H; Korf BR; Mautner VF; MacCollin M; Papi L; Rauen KA; Riccardi V; Schorry E; Smith MJ; Stemmer-Rachamimov A; Stevenson DA; Ullrich NJ; Viskochil D; Wimmer K; Yohay K; ; Huson SM; Wolkenstein P; Evans DG
    Genet Med; 2022 Sep; 24(9):1967-1977. PubMed ID: 35674741
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Bilateral intracochlear schwannomas in a patient with no genetic or clinical features of neurofibromatosis type 2. German version].
    Withers S; Plontke SK; Boeddinghaus R; Kuthubutheen J; Atlas M
    HNO; 2020 Jul; 68(7):534-538. PubMed ID: 31758201
    [TBL] [Abstract][Full Text] [Related]  

  • 31. New classification and approaches to the treatment of schwannomatosis.
    Makashova ES; Zolotova SV; Absalyamova OV; Galkin MV; Petrokovskaya AV; Kozlov AV; Golanov AV
    Zh Vopr Neirokhir Im N N Burdenko; 2023; 87(5):104-109. PubMed ID: 37830475
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A Diagnostic Dilemma: Multiple Primary Intracranial Tumors Without Vestibular Schwannomas.
    Faucett EA; Larsen BT; Khan R; Chiu AG; Chang EH
    Ann Otol Rhinol Laryngol; 2016 Nov; 125(11):938-942. PubMed ID: 27553596
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Malignant melanotic nerve sheath tumor of the posterior mediastinum].
    Buero A; Olivera Lopez SB; Tchercansky A; Pankl LG; Chimondeguy DJ; Samudio M; Mendez J; Lyons GA
    Medicina (B Aires); 2024; 84(2):324-328. PubMed ID: 38683517
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Phenotypic and genotypic overlap between mosaic NF2 and schwannomatosis in patients with multiple non-intradermal schwannomas.
    Kehrer-Sawatzki H; Kluwe L; Friedrich RE; Summerer A; Schäfer E; Wahlländer U; Matthies C; Gugel I; Farschtschi S; Hagel C; Cooper DN; Mautner VF
    Hum Genet; 2018 Jul; 137(6-7):543-552. PubMed ID: 30006736
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Surgical management of sporadic and schwannomatosis-associated pelvic schwannomas.
    Peyre M; Gaudric J; Bernat I; André A; Couture T; Kalamarides M
    Neurosurg Rev; 2023 Oct; 46(1):275. PubMed ID: 37857782
    [TBL] [Abstract][Full Text] [Related]  

  • 36. What to know about schwannomatosis: a literature review.
    Schraepen C; Donkersloot P; Duyvendak W; Plazier M; Put E; Roosen G; Vanvolsem S; Wissels M; Bamps S
    Br J Neurosurg; 2022 Apr; 36(2):171-174. PubMed ID: 33263426
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Differential diagnosis of type 2 neurofibromatosis: molecular discrimination of NF2 and sporadic vestibular schwannomas.
    Wu CL; Thakker N; Neary W; Black G; Lye R; Ramsden RT; Read AP; Evans DG
    J Med Genet; 1998 Dec; 35(12):973-7. PubMed ID: 9863591
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Familial schwannomatosis, a new entity distinct from neurofibromatosis type 1 and 2].
    Reinders JW; Koehler PJ
    Ned Tijdschr Geneeskd; 2007 Aug; 151(34):1891-5. PubMed ID: 17902564
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Available Therapies for Patients with Neurofibromatosis-Related Nervous System Tumors.
    Strowd RE
    Curr Treat Options Oncol; 2020 Aug; 21(10):81. PubMed ID: 32767156
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Targeted next-generation sequencing for differential diagnosis of neurofibromatosis type 2, schwannomatosis, and meningiomatosis.
    Louvrier C; Pasmant E; Briand-Suleau A; Cohen J; Nitschké P; Nectoux J; Orhant L; Zordan C; Goizet C; Goutagny S; Lallemand D; Vidaud M; Vidaud D; Kalamarides M; Parfait B
    Neuro Oncol; 2018 Jun; 20(7):917-929. PubMed ID: 29409008
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.